TNF-α messenger RNA and protein expression in the uteroplacental unit of mice with pregnancy loss

Journal of Immunology

Volumn 160, Issue 9, 1998, Pages 4280-4288

  Gorivodsky, Marat ^a   Zemlyak, Ilona ^a   Orenstein, Hasida ^a   Savion, Shoshana ^a   Fein, Amos ^a   Torchinsky, Arkady ^a   Toder, Vladimir ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; FETOPLACENTAL UNIT; FETUS RESORPTION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; STROMA; TROPHOBLAST;

ABORTION, SPONTANEOUS; ANIMALS; CYCLOPHOSPHAMIDE; FEMALE; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; PLACENTA; PREGNANCY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UTERUS;

EID: 0032080834     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Robetson, S. A., R. F. Seamark, L. J. Guilbert, and T. G. Wegmann. 1994. The role of cytokines in gestation. Crit. Rev. Immunol. 14:239.
2. Vassali, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.
3. Beutler, B., and A. Cerami. 1989. The biology of cachectin/TNF-α primary mediator of the host response. Annu. Rev. Immunol. 7:625.
4. Frater-Schroder, M., W. Riasu, R. Hallmann, P. Gautschi, and P. Bohlein. 1987. Tumor necrosis factor type α, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. USA 84:5277.
5. 2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 162:2163.
6. Robaye, B., R. Mosselmans, W. Fiers, J. E. Dumont, and P. Galand. 1991. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am. J. Pathol. 138:447.
7. Witsell, A. L., and L. B. Schook. 1992. Tumor necrosts factor α is an autocrine growth regulator during macrophage differentiation. Proc. Natl. Acad. Sci. USA 89:4754.
8. Terranova, P. F., V. J. Hunter, K. F. Roby, and J. S. Hunt. 1995. Tumor necrosis factor-α in the female reproductive tract. Proc. Soc. Exp. Biol. Med. 209:325.
9. Hunt, J. S., and K. F. Roby. 1995. Tumor necrosis factor-α and immunity in the female reproductive tract. In Immunology of Human Reproduction. M. Kurpisz and N. Fernandez, eds. BIOS Scientific Publishers, Oxford, U.K., p. 251.
10. Yang, Y., K. K. Yelavarthi, H.-L. Chen, J. L. Pace, P. F. Terranova, and J. S. Hunt. 1993. Molecular, biochemical and functional characteristics of tumor necrosis factor-α produced by human placental cytotrophoblastic cells. J. Immunol. 150:5614.
11. Chen, J. L., Y. Yang, X.-L. Xu, K. K. Yelavarthi, J. L. Fishback, and J. S. Hunt. 1991. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am. J. Pathol. 139:327.
12. Vince, G., S. Shorter, P. Starkey, J. Humphreys, L. Clover, T. Wilkins, I. Sargent, and C. Redman. 1992. Localization of tumor necrosis factor production in cells at the materno/fetal interface in human pregnancy. Clin. Exp. Immunol. 88:174.
13. Casey, M. L., S. M. Cox, B. Beutler, L. Milewich, and P. C. MacDonald. 1989. Cachectin/tumor necrosis factor-alpha formation in human decidua: potential role of cytokines in infection-induced preterm labor. J. Clin. Invest. 83:430.
14. Jaattela, M., P. Kuusela, and E. Saksela. 1988. Demonstration of tumor necrosis factor in human amniotic fluid and supernatants of placental and decidual tissues. Lab. Invest. 58:48.
15. Hunt, J. S., H.-L. Chen, X.-L. Hu, and J. W. Pollard. 1993. Normal distribution of tumor necrosis factor-α messenger ribonucleic acid and protein in virgin and pregnant osteopetrotic (op/op) mice. Biol. Reprod. 49:441.
16. Yelavarthi, K. K., H.-L. Chen, Y. Yang, J. L. Fishback, B. Courley, Jr., and J. S. Hunt. 1991. Tumor necrosis factor-α mRNA and protein in rat uterine and placental cells. J. Immunol. 146:3840.
17. Croy, B. A., L. J. Guilbert, M. A. Browne, N. M. Gough, D. T. Stinchcomb, N. Reed, and T. G. Wegmann. 1991. Characterization of cytokine production by the metrial gland and granulated metrial gland cells. J. Reprod. Immunol. 19:149.
18. Roby, K. F., and J. S. Hunt. 1994. Mouse endometrial tumor necrosis factor-α mRNA and protein localization and regulation by estradiol and progesterone. Endocrinology 135:2780.
19. Hunt, J. S., and S. A. Robertson. 1996. Uterine macrophages and environmental programming for pregnancy success. J. Reprod. Immunol. 32:1.
20. Tabibzadeh, S., Q. F. Kong, and X. Z. Sun. 1993. Regulatory role of TNF-α in transepithelial migration of leukocytes and epithelial dyscohesion. Endocr. J. 1:417.
21. Pampfer, S., Y.-D. Wuu, I. Vanderheyden, and R. De Hertogh. 1994. Expression of tumor necrosis factor-α receptors and selective effect of TNFα on the inner cell mass in mouse blastocysts. Endocrinology 134:206.
22. Tartakovsky, B., and E. Ben-Yair. 1991. Cytokines modulate preimplantation development and pregnancy. Dev. Biol. 146:345.
23. Hunt, J. S., R. A. Atherton, and J. L. Pace. 1990. Differential responses of rat trophoblast cells and embryonic fibroblast cells to cytokines that regulate proliferation and class I MHC antigen expression. J. Immunol. 145:184.
24. Hunt, J. S. 1996. Functional aspects of the tumor necrosis factor gene family in pregnancy. In Proceeding of the 13th Rochester Trophoblast Conference, Banff, Canada. Banff Conferences Publishing, Banff, Alberta, Canada, abstr. 38.
25. Vandenabeele, P., W. Declercq, R. Beyaert, and W. Fiers. 1995. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol. 5:392.
26. Roby, K. F., N. Laham, H. Kroning, P. F. Terranova, and J. S. Hunt. 1995. Expression and localization of messenger RNA for tumor necrosis factor receptor (TNF-R) I and TNF-RII in pregnant mouse uterus and placenta. Endocrine 3:557.
27. Romero, R., K. H. Manogue, M. D. Mitchell, Y. K. Wu, E. Oyarzun, J. C. Hobbins and A. Cerami. 1989. Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic intection and preterm labor. Am. J. Obstet. Gynecol. 161:336.
28. Chaouat, G., E. Menu, J. Szeerkeres-Bartho, C. Rebut-Bonneton, P. Bustany, R. Kinsky, and D. A. Clark. 1991. Immunological and endocrinological factors that contribute to a successful pregnancy. In Molecular and Cellular Immunology of the Fetal-Maternal Interface. T. G. Wegmann, T. G. Gill, and R. Nisbet-Brown, eds. Oxford University Press, New York, p. 277.
29. Gendron, R. L., F. P. Nestel, W. S. Lapp, and M. G. Baines. 1990. Lipopolysaccharide-induced fetal resorption in mice is associated with the intrauterine production of tumor necrosis factor-alpha. J. Reprod. Fertil. 90:395.
30. Hevborne, K. D., S. S. Witkin, and J. A. McGregor. 1992. Tumor necrosis factor-α in midtrimester amniotic fluid is associated with impaired intrauterine fetal growth. Am. J. Obstet. Gynecol. 167:920.
31. Chaouat, G., E. Menu, D. A. Clark, M. Minkowsky, M. Dy, and T. G. Wegmann. 1990. Control of fetal survival in CBA × DBA/2 mice by lymphokine therapy. J. Reprod. Fertil. 89:447.
32. Arck, P. C., A. B. Troutt, and D. A. Clark. 1997. Soluble receptors neutralizing TNF-α and IL-1 block stress-triggered murine abortion. Am. J. Reprod. Immunol. 17-262.
33. Arck, P. C., F. S. Meroli, J. Manuel, G. Chaouat, and D. A. Clark. 1995. Stress-triggered abortion: inhibition of protective suppression and promotion of tumor necrosis factor-α (TNF-α) release as a mechanism triggering resorptions in mice. Am. J. Reprod. Immunol. 33:74.
34. Chaouat, G., E. Menu, J. Szeerkeres-Bartho, C. Rebut-Bonneton, P. Bustany, R. Kinsky, D. A. Clark, and T. G. Wegmann. 1989. Lymphokines, steroids, placental factors and trophoblast intrinsic resistance to immune cell-mediated lysis are involved in pregnancy success or immunologically mediated pregnancy failure. In Molecular Biology of the Felo-Maternal Interface. T. G. Wegmann and T. G. Gill, eds. Oxford University Press, New York. p. 213.
35. Tangri, S., and R. Raghupathy. 1993. Expression of cytokines in placentas of mice undergoing immunologically mediated spontaneous fetal resorptions. Biol. Reprod. 49:850.
36. Tangri, S., T. G. Wegmann, H. Lin, and R. Raghupathy. 1994. Maternal anti-placental reactivity in natural, immunologically mediated fetal resorptions. J. Immunol. 152:4903.
37. Chaouat, G., N. Kiger, and T. G. Wegmann. 1983. Vaccination against spontaneous abortion in mice. J. Reprod. Immunol. 5:389.
38. Toder, V., D. Strassburger, H. Carp, Y. Irlin, S. Lurie, M. Pecht, and N. Trainin. 1988. Immunopotentiation and pregnancy loss. J. Reprod. Fertil. 37(Suppl.):1.
39. Torchinsky, A., A. Fein, H. J. A. Carp, and V. Toder. 1994. MHC-associated immunopotentiation affects the embryo response to teratogens. Clin. Exp. Immunol. 98:513.
40. Torchinsky, A., V. Toder, S. Savion, J. Shepshelovich, H. Orenstein, and A. Fein. 1997. Immunostimulation increases the resistance of mouse embryos to the teratogenic effect of diabetes mellitus. Diabetologia 40:635.
41. Wegmann, T. G. 1990. The cytokine basis for cross-talk between the maternal immune and reproductive systems. Curr. Opin. Immunol. 2:765.
42. Toder, V., D. Strassburger, Y. Irlin, H. Carp, M. Pecht, and N. Trainin. 1990. Nonspecific immunopotentiators and pregnancy loss: complete Freund adjuvant reverses high fetal resorption rate in CBA × DBA/2 mouse combination. Am. J. Reprod. Immunol. 24:63.
43. Toder, V., S. Savion, M. Gorivodsky, J. Shepshelovich, Z. Zaslavsky, A. Fein, and Torchinsky. 1996. Teratogen-induced apoptosis may be affected by immunopotentiation. J. Reprod. Immunol. 30:173.
44. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
45. Sasson, D., and N. Rosenthal. 1993. Detection of messenger RNA by in situ hybridization. 1993. Methods Enzymol. 225:384.
46. Beutler, B., and T. Brown. 1993. Polymorphism of the mouse TNF-α locus: sequence studies of the 3′-untranslated region and first intron. Gene 129:279.
47. Freund, Y. R., G. Sgarlato, C. O. Jacob, Y. Suzuki, and J. S. Remington. 1996. Polymorphism in the tumor necrosis factor-α (TNF-α) gene correlates with murine resistance to development of toxoplasmic encephalitis and with levels of TNF-α mRNA in injected brain tissue. J. Exp. Med. 175:683.
48. Cabrera, M., M. A. Shaw, C. Sharples, H. Williams, M. Castes, J. Convit, and J. M. Blackwell. 1995 Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J. Exp. Med. 182:1259.
49. Vincek, V., I. Kurimoto, J. P. Medema, E. Prieto, and J. W. Streilein. 1993. Tumor necrosis factor alpha polymorphism correlates with deleterious effects of ultraviolet B light on cutaneous immunity. Cancer Res. 53:728.
50. Cseh, K., and B. Beutler. 1989. Alternative cleavage of the cachectin/tumor necrosis factor propeptide results in a larger inactive form of secreted protein. J. Biol. Chem. 264:16256.
51. Roby, K. F., N. Laham, H. Kroning, P. F. Terranova, and J. S. Hunt. 1995. Expression and localization of messenger RNA for tumor necrosis factor receptor (TNF-R) I and TNF-RII in pregnant mouse uterus and placenta. Endocrine 3:557.
52. Yui, J., M. Garcia-Lloret, T. G. Wegmann, and L. J. Guilbert. 1994. Cytotoxicity of tumor necrosis factor-alpha and gamma-interferon against primary human placental trophoblast. Placenta 15:819.